Moderna (MRNA) ended the recent trading session at $25.90, demonstrating a +1.97% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Elsewhere, ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

The epidemiologist and immunologist Michael Mina called Kennedy’s move a “code red” for vaccines in America. None of the ...

U.S. Senate Democrats demanded on Wednesday Health Secretary Robert F. Kennedy Jr. make public the reviews on which his ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

A BU professor warns that federal funding cuts, immigration restrictions and housing costs could reshape the region's status ...

Los humanos son el único animal que vive en prácticamente todos los entornos posibles, desde selvas tropicales hasta ...

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...

Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial ...

In spring training for the 2024 season, the Railroaders were set to have another intra-team scrimmage with Austin Faith taking the mound as one of the starting pitchers. Faith had a weird feeling all ...

The false claim is that scientists have warned mRNA vaccines are causing people to become "literal spastics" - causing ...